S&P 500   5,137.18 (+0.80%)
DOW   39,092.88 (+0.25%)
QQQ   445.89 (+1.57%)
AAPL   179.64 (-0.61%)
MSFT   415.71 (+0.50%)
META   502.61 (+2.55%)
GOOGL   137.24 (-0.88%)
AMZN   178.62 (+1.05%)
TSLA   202.96 (+0.53%)
NVDA   820.71 (+3.74%)
NIO   5.78 (+0.52%)
AMD   201.84 (+4.84%)
BABA   74.75 (+0.97%)
T   17.02 (+0.53%)
F   12.41 (-0.24%)
MU   95.20 (+5.07%)
CGC   3.20 (-2.74%)
GE   158.71 (+1.16%)
DIS   112.05 (+0.42%)
AMC   4.38 (+1.39%)
PFE   26.57 (+0.04%)
PYPL   60.61 (+0.45%)
XOM   105.80 (+1.22%)
S&P 500   5,137.18 (+0.80%)
DOW   39,092.88 (+0.25%)
QQQ   445.89 (+1.57%)
AAPL   179.64 (-0.61%)
MSFT   415.71 (+0.50%)
META   502.61 (+2.55%)
GOOGL   137.24 (-0.88%)
AMZN   178.62 (+1.05%)
TSLA   202.96 (+0.53%)
NVDA   820.71 (+3.74%)
NIO   5.78 (+0.52%)
AMD   201.84 (+4.84%)
BABA   74.75 (+0.97%)
T   17.02 (+0.53%)
F   12.41 (-0.24%)
MU   95.20 (+5.07%)
CGC   3.20 (-2.74%)
GE   158.71 (+1.16%)
DIS   112.05 (+0.42%)
AMC   4.38 (+1.39%)
PFE   26.57 (+0.04%)
PYPL   60.61 (+0.45%)
XOM   105.80 (+1.22%)
S&P 500   5,137.18 (+0.80%)
DOW   39,092.88 (+0.25%)
QQQ   445.89 (+1.57%)
AAPL   179.64 (-0.61%)
MSFT   415.71 (+0.50%)
META   502.61 (+2.55%)
GOOGL   137.24 (-0.88%)
AMZN   178.62 (+1.05%)
TSLA   202.96 (+0.53%)
NVDA   820.71 (+3.74%)
NIO   5.78 (+0.52%)
AMD   201.84 (+4.84%)
BABA   74.75 (+0.97%)
T   17.02 (+0.53%)
F   12.41 (-0.24%)
MU   95.20 (+5.07%)
CGC   3.20 (-2.74%)
GE   158.71 (+1.16%)
DIS   112.05 (+0.42%)
AMC   4.38 (+1.39%)
PFE   26.57 (+0.04%)
PYPL   60.61 (+0.45%)
XOM   105.80 (+1.22%)
S&P 500   5,137.18 (+0.80%)
DOW   39,092.88 (+0.25%)
QQQ   445.89 (+1.57%)
AAPL   179.64 (-0.61%)
MSFT   415.71 (+0.50%)
META   502.61 (+2.55%)
GOOGL   137.24 (-0.88%)
AMZN   178.62 (+1.05%)
TSLA   202.96 (+0.53%)
NVDA   820.71 (+3.74%)
NIO   5.78 (+0.52%)
AMD   201.84 (+4.84%)
BABA   74.75 (+0.97%)
T   17.02 (+0.53%)
F   12.41 (-0.24%)
MU   95.20 (+5.07%)
CGC   3.20 (-2.74%)
GE   158.71 (+1.16%)
DIS   112.05 (+0.42%)
AMC   4.38 (+1.39%)
PFE   26.57 (+0.04%)
PYPL   60.61 (+0.45%)
XOM   105.80 (+1.22%)

Science 37 (SNCE) Competitors

$5.74
+0.01 (+0.17%)
(As of 03:35 PM ET)

SNCE vs. BIAF, AIKI, EFTR, POCI, AKUMQ, CDIO, XGN, CODX, TCRT, and GSDI

Should you be buying Science 37 stock or one of its competitors? The main competitors of Science 37 include bioAffinity Technologies (BIAF), AIkido Pharma (AIKI), eFFECTOR Therapeutics (EFTR), Precision Optics (POCI), Akumin (AKUMQ), Cardio Diagnostics (CDIO), Exagen (XGN), Co-Diagnostics (CODX), Alaunos Therapeutics (TCRT), and Global System Dynamics (GSDI). These companies are all part of the "medical" sector.

Science 37 vs.

Science 37 (NASDAQ:SNCE) and bioAffinity Technologies (NASDAQ:BIAF) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, community ranking, media sentiment, institutional ownership, profitability and dividends.

In the previous week, bioAffinity Technologies had 1 more articles in the media than Science 37. MarketBeat recorded 3 mentions for bioAffinity Technologies and 2 mentions for Science 37. Science 37's average media sentiment score of 0.94 beat bioAffinity Technologies' score of 0.44 indicating that Science 37 is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Science 37
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
bioAffinity Technologies
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Science 37 has a beta of 0.53, indicating that its share price is 47% less volatile than the S&P 500. Comparatively, bioAffinity Technologies has a beta of 3.63, indicating that its share price is 263% more volatile than the S&P 500.

Science 37 received 9 more outperform votes than bioAffinity Technologies when rated by MarketBeat users.

CompanyUnderperformOutperform
Science 37Outperform Votes
9
42.86%
Underperform Votes
12
57.14%
bioAffinity TechnologiesN/AN/A

Science 37 has a net margin of -206.86% compared to bioAffinity Technologies' net margin of -2,244.15%. bioAffinity Technologies' return on equity of -80.82% beat Science 37's return on equity.

Company Net Margins Return on Equity Return on Assets
Science 37-206.86% -83.09% -61.58%
bioAffinity Technologies -2,244.15%-80.82%-69.38%

bioAffinity Technologies has lower revenue, but higher earnings than Science 37.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Science 37$70.15M0.49-$50.99M-$21.40-0.27
bioAffinity TechnologiesN/AN/A-$8.15MN/AN/A

40.7% of Science 37 shares are owned by institutional investors. Comparatively, 1.1% of bioAffinity Technologies shares are owned by institutional investors. 6.8% of Science 37 shares are owned by insiders. Comparatively, 44.3% of bioAffinity Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Science 37 currently has a consensus target price of $20.00, indicating a potential upside of 248.43%. Given Science 37's higher possible upside, research analysts clearly believe Science 37 is more favorable than bioAffinity Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Science 37
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
bioAffinity Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Science 37 beats bioAffinity Technologies on 7 of the 12 factors compared between the two stocks.


Get Science 37 News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNCE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNCE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNCE vs. The Competition

MetricScience 37Commercial physical research IndustryMedical SectorNASDAQ Exchange
Market Cap$34.27M$5.10B$4.98B$7.61B
Dividend YieldN/A0.94%2.88%3.87%
P/E Ratio-0.2710.70213.9315.58
Price / Sales0.4982.253,026.9675.40
Price / CashN/A28.0696.4954.95
Price / Book0.343.984.564.72
Net Income-$50.99M$106.02M$114.35M$211.39M
7 Day Performance0.53%8.07%5.61%3.41%
1 Month Performance0.88%10.44%10.28%6.26%
1 Year Performance-11.04%0.35%13.70%9.58%

Science 37 Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIAF
bioAffinity Technologies
0 of 5 stars
$2.06
+13.2%
N/A+36.5%$19.57MN/A0.0014Short Interest ↑
News Coverage
High Trading Volume
AIKI
AIkido Pharma
0 of 5 stars
$2.14
+3.9%
N/A-41.9%$11.71M$10,000.00-0.554
EFTR
eFFECTOR Therapeutics
2.7243 of 5 stars
$13.14
+13.1%
$99.50
+657.2%
+15.9%$33.90M$3.55M-0.6915News Coverage
High Trading Volume
POCI
Precision Optics
0 of 5 stars
$5.63
-1.6%
N/A-23.4%$34.17M$21.05M-18.7784Positive News
Gap Up
High Trading Volume
AKUMQ
Akumin
0 of 5 stars
$0.38
-6.3%
N/AN/A$34.19M$749.63M-0.133,631Gap Down
CDIO
Cardio Diagnostics
0 of 5 stars
$1.67
-5.6%
N/A-53.0%$34.30MN/A0.007Upcoming Earnings
XGN
Exagen
4.8964 of 5 stars
$1.97
+1.0%
$5.50
+179.2%
-11.8%$33.59M$45.56M-1.06199Short Interest ↓
News Coverage
Positive News
CODX
Co-Diagnostics
3.493 of 5 stars
$1.13
+0.9%
$3.00
+165.5%
-60.9%$34.56M$4.66M-0.81145Short Interest ↑
News Coverage
TCRT
Alaunos Therapeutics
2.0356 of 5 stars
$2.16
-3.1%
$45.00
+1,983.3%
-74.9%$34.67M$2.92M-0.9034Upcoming Earnings
Positive News
GSDI
Global System Dynamics
0 of 5 stars
$10.51
flat
N/AN/A$34.79MN/A0.00N/A

Related Companies and Tools

This page (NASDAQ:SNCE) was last updated on 3/1/2024 by MarketBeat.com Staff